Oleg V Krokhin Selected Research

IDR 1002

1/2021

Disrupting Tryptophan in the Central Hydrophobic Region Selectively Mitigates Immunomodulatory Activities of the Innate Defence Regulator Peptide IDR-1002.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oleg V Krokhin Research Topics

Disease

1	Respiratory Hypersensitivity 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Carcinoma (Carcinomatosis) 01/2019
1	Rheumatoid Arthritis 01/2009
1	Necrosis 01/2009
1	Fabry Disease (Fabry's Disease) 02/2007

Drug/Important Bio-Agent (IBA)

2	Biological ProductsIBA 01/2009 - 02/2007
1	Peptides (Polypeptides)IBA 01/2021
1	IDR 1002IBA 01/2021
1	PhosphopeptidesIBA 01/2019
1	CationsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	ProteomeIBA 01/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2009
1	Infliximab (Remicade)FDA Link 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	alpha-Galactosidase (Beano)IBA 02/2007
1	agalsidase alfaIBA 02/2007

Therapy/Procedure

1	Immunomodulation 01/2021
1	Therapeutics 01/2009
1	Enzyme Replacement Therapy 02/2007